C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/03/2002	CA2320008C Brassica transformation via microprojectile bombardment
12/03/2002	CA2284077C Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
12/03/2002	CA2254853C Compositions and methods for screening antimicrobials
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2060544C Recombinant antibodies specific for a growth factor receptor
12/03/2002	CA2050910C Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
12/01/2002	CA2384109A1 Engineering nicking endonucleases from type iis restriction endonucleases
11/2002
11/30/2002	CA2388268A1 Methods of determining polypeptide structure and function
11/30/2002	CA2384352A1 Novel polynucleotides from streptomyces avermitilis
11/29/2002	WO2001092476A2 In vitro tissue test system
11/29/2002	CA2410946A1 In vitro tissue test system
11/28/2002	WO2002095654A1 Methods for predicting the activities of cellular constituents
11/28/2002	WO2002095363A2 Methods for attenuation of virulence in bacteria
11/28/2002	WO2002095073A1 Method for the synthesis of dna sequences
11/28/2002	WO2002095072A1 COLONY ARRAY-BASED cDNA LIBRARY NORMALIZATION BY HYBRIDIZATIONS OF COMPLEX RNA PROBES AND GENE SPECIFIC PROBES
11/28/2002	WO2002095070A2 Polynucleotide sequencing method
11/28/2002	WO2002095068A2 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095059A2 Selection of target sites for antisense attack of rna
11/28/2002	WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002	WO2002095055A2 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002	WO2002095053A2 Antisense modulation of src-c expression
11/28/2002	WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	WO2002095047A1 Acetate-free purification of plasmid dna on hydroxyapatite
11/28/2002	WO2002095043A1 Cellular signal-responsive gene transcriptional regulation system
11/28/2002	WO2002095042A1 Recombinant adenovirus vector producing tumor-suppressor e2 protein and the use thereof
11/28/2002	WO2002095041A1 Virus high effectively expressing the tumor interferon and specifically reproduction in tumor cells and the use thereof
11/28/2002	WO2002095040A1 Delections in arterivirus replicons
11/28/2002	WO2002095039A1 Protease deficient caulobacter host cells
11/28/2002	WO2002095038A2 Vectors for enhanced expression of vegf for disease treatment
11/28/2002	WO2002095037A1 Double selection cloning method and vectors therefor
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002095035A1 Crystal structure of ketopantoate reductase and use thereof
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095033A2 Sequence of the tropheryma whippelii bacteria rpob gene and oligonucleotide for molecular diagnosis of whipple's disease
11/28/2002	WO2002095032A2 Methods and compositions of human proteins and uses thereof.
11/28/2002	WO2002095031A1 Dna molecule with insulating activity against chromosomal position effects in gene transfer processes in animal cells
11/28/2002	WO2002095030A2 Modulation of cd200 receptors
11/28/2002	WO2002095029A2 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002	WO2002095027A2 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	WO2002095025A1 Novel smg-1
11/28/2002	WO2002095024A1 Method for constructing a chimeric dna library using a single strand specific dnase
11/28/2002	WO2002095023A2 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	WO2002095021A2 A repressor-mediated regulation system for control of gene expression in plants
11/28/2002	WO2002095020A1 A gene and uses therefor
11/28/2002	WO2002095018A1 Regulation of human zinc carboxypeptidase b-like protein
11/28/2002	WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	WO2002095016A2 Champ - a cardiac helicase-like factor
11/28/2002	WO2002095014A2 Polypeptides having cellobiase activity and polynucleotides encoding same
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095008A2 Methods of modulating surfactant phospholipid production
11/28/2002	WO2002095006A2 Muscle-specific expression vectors
11/28/2002	WO2002095005A2 Therapeutic dna vaccination
11/28/2002	WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002	WO2002095002A2 N4 virion single-stranded dna dependent rna polymerase
11/28/2002	WO2002094999A2 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094995A2 Methods and compositions using genetic package display
11/28/2002	WO2002094994A2 Chimeric antigen-specific t cell-activating polypeptides
11/28/2002	WO2002094992A2 Directed evolution of protein in mammalian cells
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094989A2 Retroviral vectors and methods of using same
11/28/2002	WO2002094986A2 Next-nearest-neighbor sequence determinants of antisense dna
11/28/2002	WO2002094983A2 Dna-antibody complexes to enhance gene transfer
11/28/2002	WO2002094980A2 Phytocystatin
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	WO2002094880A1 Anti-trail-r antibodies
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002094877A2 New nuclear receptor cofactors and related modulators
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002	WO2002094874A2 Internalisation of virus into cells
11/28/2002	WO2002094872A1 Therapeutic uses of keratinocyte growth factor-2
11/28/2002	WO2002094871A1 Novel keratinocyte growth factor-2 analogue in hair follicle
11/28/2002	WO2002094870A2 Proteins and nucleic acids encoding same
11/28/2002	WO2002094868A2 Staphylococcus aureus proteins and nucleic acids
11/28/2002	WO2002094867A2 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/28/2002	WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002	WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002	WO2002094855A2 Peptide synthesis method
11/28/2002	WO2002094853A2 Antibodies specific for poly(ethylene glycol)
11/28/2002	WO2002094852A2 Taci-immunoglobulin fusion proteins
11/28/2002	WO2002094848A1 Treatment of mycobacterium tuberculosis with antisense oligonucleotides
11/28/2002	WO2002094847A1 Antisense modulation of ptpn2 expression
11/28/2002	WO2002094845A2 Method for stabilising of nucleic acids
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094318A1 Vector for targeted delivery to cells
11/28/2002	WO2002094314A1 Tsg101 as inhibitor of hiv production
11/28/2002	WO2002094313A2 Vaccine composition
11/28/2002	WO2002094250A2 Therapeutic uses of lna-modified oligonucleotides in infectious diseases
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)

1 ... 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 ... 4023